Sarepta Therapeutics Inc. (SRPT) Stock: Jason Karp Is A Shareholder Again And Has A Larger Position Than Ever

Page 7 of 8 – SEC Filing
SIGNATURES
After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.
Dated:
October 28, 2016
TOURBILLON CAPITAL PARTNERS LP
By:  /s/ Brian A. Kessler
              Brian A. Kessler,
              Chief Financial Officer
/s/ Jason H. Karp
     Jason H. Karp

Follow Sarepta Therapeutics Inc. (NASDAQ:SRPT)